Ulrich Massing - Concepedia

Author

Ulrich Massing

University Medical Center Freiburg ORCID

Also Known As

Massing U., Massing, Ulrich, U MASSING, U Massing, U. MASSING, U. Massing, Ulrich Massing

137

Publications

Citations

H-Index

102

Concepts

All Affiliations

University Medical Center Freiburg University of Freiburg Hettich (Germany)Heidelberg University University of Bonn

About

Ulrich Massing is an author at University Medical Center Freiburg specializing in medicine, engineering, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	869
2	Engineering	14	16	578
3	Natural Sciences	3	3	85
4	Health Sciences	1	1	98
5	Public Health	1	1	64

Ulrich Massing

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status Lenka A. Taylor, Jann Arends, Arwen K. Hodina, Lipids in Health and Disease	2007	160
Dual asymmetric centrifugation (DAC)—A new technique for liposome preparation Ulrich Massing, Sanja Cicko, Vittorio Ziroli Journal of Controlled Release Lipid PreparationLiposome PreparationDrug Delivery SystemsAnalytical UltracentrifugationLipid Chemistry	2007	155
Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study K. Mross, Bernward Niemann, Ulrich Massing, Cancer Chemotherapy and Pharmacology Solid TumorsMedicinePharmacologyLiposomal DoxorubicinPharmacotherapy	2004	135
Biophysical and lipofection studies of DOTAP analogs Anne Regelin, Stefan Fankhaenel, Laura Gürtesch, Biochimica et Biophysica Acta (BBA) - Biomembranes Lipid PreparationDotap AnalogsBiophysicsLipid Movement	2000	104
5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties N. Kaiser, Andrea Kimpfler, Ulrich Massing, International Journal of Pharmaceutics Lipid PreparationNanomedicineMedicinal ChemistryRelease PropertiesHealth Sciences	2003	98
Liposomal formulations of anticancer drugs: selectivity and effectiveness Ulrich Massing, Stefan Fuxius Drug Resistance Updates Lipid PreparationMedicinal ChemistryMedicineLiposomal FormulationsAnti-cancer Agent	2000	83
Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels Rainer Moog, A. M. Burger, Martin Brandl, Cancer Chemotherapy and Pharmacology Human Tumor XenograftsPolymer-drug ConjugateMedicinePharmacotherapyAnti-cancer Agent	2002	78
Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial Kristin Werner, Daniela Kuellenberg de Gaudry, Lenka A. Taylor, Lipids in Health and Disease	2017	78
Preparation of small amounts of sterile siRNA-liposomes with high entrapping efficiency by dual asymmetric centrifugation (DAC) Markus Hirsch, Vittorio Ziroli, Mark Helm, Journal of Controlled Release Lipid PreparationNanomedicineBiomanufacturingEngineeringBiotechnology	2008	73
Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases Anna Raynor, Peter Jantscheff, T Ross, Lipids in Health and Disease	2015	72

Page 1